Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Aokang Biological Technology is a specialized biotechnology firm based in Linyi, China, dedicated to the industrialization of functional oligosaccharides. Established in 2004, the company has become a prominent producer of stachyose, a prebiotic tetrasaccharide extracted from the tubers of Stachys sieboldii. Its operations encompass the entire value chain, from raw material cultivation to advanced extraction, purification, and commercial distribution. The company's products are widely utilized in healthcare supplements and functional foods to promote intestinal health by selectively stimulating the growth of beneficial gut bacteria. Shandong Aokang maintains rigorous quality standards, holding certifications such as GMP, ISO9001, and HACCP to support its domestic and international market presence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Aokang Biological Technology.